I agree sulaco. Its not too often that one can find a stock with this much potential early on "before" a partnership occurs. Finding the right biotech partner than can advance the PS targeting platform is very important to Peregrine I believe and after seeing all the Big Pharma (illegal side deals) to pay a biotech to delay their drug pipeline makes it even more important for Peregrine to do their due diligence on having the terms of the deal exactly the way they need them to clearly leave no loopholes for their Big Pharma partner to hold back from running hundreds of PS targeting and/or combinational trials.
A Big Pharma partner may lose out on their current drug pipelines as those revenues are slowly moved over to Peregrines profits so I can easily see how any Big Pharma may "not" want to advance Bavi and PS targeting as fast as Peregrine wants to move it forward.
This, of course .... leads the door wide open for other groups such as Calico to back Peregrine, where they have "NO" incentive to hold back the progress of the PS targeting Platform.